An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients

被引:0
作者
Smith, Allen M. [1 ]
Shah, Anuj [2 ]
Martin, Bradley C. [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Pharm Practice, Div Pharmaceut Evaluat & Policy, 4301 Markham,Slot 522, Little Rock, AR 72205 USA
[2] AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878 USA
关键词
long-term opioid use; prescribed opioids; pain etiology; days' supply; UNITED-STATES; CHRONIC PAIN; TRENDS; IMPACT; ASSOCIATION; GUIDELINE; VETERANS; TIME;
D O I
10.1016/j.drugalcdep.2024.112463
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objectives: This retrospective cohort study provides an updated view on the association between the likelihood of long-term opioid use (LTOU) and characteristics of the initial opioid prescription (dose, opioid type) and initial opioid prescription episode (days' supplied) among opioid-na & iuml;ve patients utilizing IQVIA PharMetrics (R) Plus for Academics database representative of commercially insured patients in the US. Methods: Kaplan-Meier estimates were used to determine opioid continuation likelihood at 365 days stratified by the characteristics of the initial opioid prescription and initial opioid prescription episode. Cox-proportional hazard models were estimated to determine the strength of association between initial opioid prescription characteristics and opioid continuation. Results: A total of 578,403 cancer-free, SUD-free, opioid-na & iuml;ve subjects aged >= 14 years that filled >= 1 opioid prescriptions between April 13, 2016 and April 18, 2020 were identified and categorized based on time to opioid discontinuation. After accounting for censoring, 5.05 % of persons continued opioid use for >= 365 days. Compared to a 1-2 days' supply (DS), the likelihood of opioid discontinuation was consistently lower with higher DS [HRs (CIs): 3-4 days' supply = 0.66 (0.65-0.66); 5-7 DS = 0.41 (0.41-0.41); 8-10 DS = 0.33 (0.33-0.34); 11-14 DS = 0.30 (0.29-0.31); 15-21 DS = 0.26 (0.26-0.27); >= 22 DS = 0.17 (0.17-0.18)]. These associations between increased DS and decreased likelihood of discontinuing opioid remained consistent across different pain etiologies. Conclusions: In this era of more conservative opioid prescribing, increases in DS remains the strongest factor associated with a higher likelihood of LTOU.
引用
收藏
页数:10
相关论文
共 56 条
[1]  
[Anonymous], 2016, Prescrire Int, V25, P45
[2]  
[Anonymous], 2020, Trends and Statistics
[3]  
[Anonymous], 2022, Agency for Healthcare Research and Quality: A profile
[4]  
[Anonymous], 2019, NATL C STATE LEGISLA
[5]   Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012-2019 [J].
Bandara, Sachini ;
Bicket, Mark C. C. ;
McGinty, Emma E. E. .
PLOS ONE, 2022, 17 (08)
[6]   Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers [J].
Barrett, Alexis K. ;
Sandbrink, Friedhelm ;
Mardian, Aram ;
Oliva, Elizabeth M. ;
Torrise, Virginia ;
Zhang, Rongping ;
Bukowski, Kenneth ;
Burk, Muriel ;
Cunningham, Francesca E. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (16) :4037-4046
[7]   Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014 [J].
Burke, Laura G. ;
Zhou, Xiner ;
Boyle, Katherine L. ;
Orav, E. John ;
Bernson, Dana ;
Hood, Maria-Elena ;
Land, Thomas ;
Bharel, Monica ;
Frakt, Austin B. .
ADDICTION, 2020, 115 (03) :493-504
[8]  
CADCA, 2016, DOJ Comprehensive Addiction and Recovery Programs-Prescription Drug Monitoring
[9]  
Centers for disease control and prevention, 2015, International Classification of Diseases, Tenth Revision, Clinical Modification
[10]  
Centers for Disease Control and Prevention (CDC), 2021, U.S. Opioid Dispensing Rate Maps